Royal Bank of Canada’s Replimune Group REPL Stock Holding History

Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake
Trade Value Portfolio Weight Portfolio Position
2026
Q1
$2K Sell
350
-1,952
-85% -$14.9K ﹤0.01% 6749
2025
Q4
$22K Sell
2,302
-54,318
-96% -$462K ﹤0.01% 5992
2025
Q3
$237K Sell
56,620
-11,359
-17% -$72.6K ﹤0.01% 4987
2025
Q2
$631K Buy
67,979
+62,749
+1,200% +$548K ﹤0.01% 4280
2025
Q1
$51K Sell
5,230
-2,753
-34% -$34.1K ﹤0.01% 5568
2024
Q4
$97K Sell
7,983
-557
-7% -$6.77K ﹤0.01% 5359
2024
Q3
$93K Buy
8,540
+583
+7% +$5.92K ﹤0.01% 5393
2024
Q2
$72K Buy
7,957
+4,059
+104% +$28.3K ﹤0.01% 5467
2024
Q1
$32K Sell
3,898
-15,417
-80% -$126K ﹤0.01% 5715
2023
Q4
$163K Buy
19,315
+10,027
+108% +$116K ﹤0.01% 5266
2023
Q3
$159K Sell
9,288
-12,955
-58% -$254K ﹤0.01% 5008
2023
Q2
$517K Buy
22,243
+9,753
+78% +$191K ﹤0.01% 3930
2023
Q1
$220K Buy
12,490
+5,564
+80% +$132K ﹤0.01% 4541
2022
Q4
$189K Buy
6,926
+4,118
+147% +$85.6K ﹤0.01% 4928
2022
Q3
$49K Buy
2,808
+324
+13% +$6.18K ﹤0.01% 5749
2022
Q2
$43K Sell
2,484
-1,685
-40% -$27.7K ﹤0.01% 5779
2022
Q1
$70K Sell
4,169
-3,812
-48% -$71.9K ﹤0.01% 5870
2021
Q4
$217K Buy
7,981
+3,177
+66% +$95K ﹤0.01% 5259
2021
Q3
$143K Buy
4,804
+657
+16% +$21.3K ﹤0.01% 5445
2021
Q2
$159K Buy
4,147
+873
+27% +$29.9K ﹤0.01% 5272
2021
Q1
$100K Buy
3,274
+1,122
+52% +$42K ﹤0.01% 5465
2020
Q4
$82K Sell
2,152
-2,253
-51% -$93.9K ﹤0.01% 5438
2020
Q3
$102K Buy
4,405
+1,611
+58% +$36.7K ﹤0.01% 4968
2020
Q2
$69K Buy
2,794
+754
+37% +$13.3K ﹤0.01% 5063
2020
Q1
$20K Sell
2,040
-585
-22% -$8.72K ﹤0.01% 5549
2019
Q4
$37K Buy
2,625
+592
+29% +$8.53K ﹤0.01% 5589
2019
Q3
$28K Buy
2,033
+908
+81% +$11.1K ﹤0.01% 5358
2019
Q2
$16K Hold
1,125
﹤0.01% 5813
2019
Q1
$17K Buy
1,125
+1,111
+7,936% +$13.8K ﹤0.01% 5731
2018
Q4
$0 Sell
14
-226
-94% -$3.05K ﹤0.01% 7048
2018
Q3
$4K Buy
+240
New +$4.21K ﹤0.01% 6353

Other funds holding REPL

Royal Bank of Canada's REPL Position: Q1 2026 in Review

Royal Bank of Canada reduced its Replimune Group (REPL) stake by 85% in Q1 2026, selling an estimated $14.9K and leaving 350 shares worth $2K. The position accounts for ﹤0.01% of the portfolio, ranked #6749.

Royal Bank of Canada first reported a position in REPL in Q3 2018 and has held it in 31 quarters since. The position peaked at $631K in Q2 2025. 180 funds tracked by Wall St. Rank hold REPL as of Q1 2026.

  • Royal Bank of Canada held 350 shares of Replimune Group worth $2K as of Q1 2026.
  • Royal Bank of Canada sold 1,952 Replimune Group shares in Q1 2026, an estimated $14.9K.
  • Replimune Group made up ﹤0.01% of Royal Bank of Canada's portfolio in Q1 2026, its #6749 holding.
  • Royal Bank of Canada first reported a position in Replimune Group in Q3 2018 and has held it in 31 quarters since.
  • Royal Bank of Canada's Replimune Group position peaked at $631K in Q2 2025.
  • 180 funds tracked by Wall St. Rank held Replimune Group as of Q1 2026.

Based on Royal Bank of Canada's 13F filing for Q1 2026, filed 15 May 2026.